John S. Welch

23.7k total citations · 5 hit papers
141 papers, 10.2k citations indexed

About

John S. Welch is a scholar working on Hematology, Molecular Biology and Surgery. According to data from OpenAlex, John S. Welch has authored 141 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hematology, 39 papers in Molecular Biology and 21 papers in Surgery. Recurrent topics in John S. Welch's work include Acute Myeloid Leukemia Research (37 papers), Retinoids in leukemia and cellular processes (19 papers) and Cancer Genomics and Diagnostics (9 papers). John S. Welch is often cited by papers focused on Acute Myeloid Leukemia Research (37 papers), Retinoids in leukemia and cellular processes (19 papers) and Cancer Genomics and Diagnostics (9 papers). John S. Welch collaborates with scholars based in United States, Australia and Spain. John S. Welch's co-authors include Mercedes Ricote, Christopher K. Glass, Timothy J. Ley, Matthew J. Walter, Richard K. Wilson, Christopher A. Miller, Li Ding, Michael C. Wendl, Joshua F. McMichael and Michael D. McLellan and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

John S. Welch

134 papers receiving 10.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mutational landscape and significance across 12 major cancer types

2013 3.1k citations Cyriac Kandoth, Michael D. McLellan et al. Nature profile →
Age-related mutations associated with clonal hematopoietic expansion and malignancies

2014 1.2k citations Mingchao Xie, Charles Lu et al. profile →
15-Deoxy-Δ ^12,14 -prostaglandin J ₂ inhibits multiple steps in the NF-κB signaling pathway

2000 906 citations John S. Welch, Mercedes Ricote et al. profile →
Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase

1999 749 citations John S. Welch, Mercedes Ricote et al. Nature profile →
Expression of the peroxisome proliferator-activated receptor γ (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

1998 631 citations Mercedes Ricote, John S. Welch et al. profile →

Peers

Countries citing papers authored by John S. Welch

Since Specialization

Citations

This map shows the geographic impact of John S. Welch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. Welch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. Welch more than expected).

Fields of papers citing papers by John S. Welch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John S. Welch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. Welch. The network helps show where John S. Welch may publish in the future.

Co-authorship network of co-authors of John S. Welch

This figure shows the co-authorship network connecting the top 25 collaborators of John S. Welch. A scholar is included among the top collaborators of John S. Welch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John S. Welch. John S. Welch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recommendations for Defining Chimeric Antigen Receptor T-Cell (CAR T) Dose-Limiting Toxicities (DLTs) for Future Early-Phase CAR T Therapy Studies 2025 ·Transplantation and Cellular Therapy ·Frederick L. Locke, Sarah Nikiforow, Matthew J. Frigault, David G. Maloney, Marco L. Davila, David B. Miklos, (unknown), (unknown), Nirav N. Shah, Sattva S. Neelapu, John S. Welch, (unknown), Caron A. Jacobson, Marcela V. Maus	0
2	Improving ethnic and racial diversity in biomarker-driven clinical trials: A proof of concept with the BASECAMP-1 master prescreening study of patients with high-risk solid tumors with human leukocyte antigen-A02 (HLA-A02) loss of heterozygosity (LOH). 2024 ·Journal of Clinical Oncology ·(unknown), Diane M. Simeone, Patrick Grierson, Kedar Kirtane, Maria Pia Morelli, Sandip Pravin Patel, Matthew L. Ulrickson, Saurabh Dahiya, Jong Chul Park, Jennifer M. Specht, Marwan Fakih, (unknown), Jessica Tebbets, John S. Welch, William Y. Go, David G. Maloney, Marcela V. Maus, (unknown), J. Randolph Hecht	0
3	EVEREST-2: A seamless phase 1/2 study of A2B694, a mesothelin (MSLN) logic-gated Tmod CAR T-cell therapy, in patients with solid tumors that show MSLN expression and human leukocyte antigen (HLA)-A02 loss of heterozygosity (LOH). 2024 ·Journal of Clinical Oncology* ·Salman R. Punekar, J. Randolph Hecht, (unknown), Diane M. Simeone, Oliver Dorigo, Leslie R. Boyd, Kedar Kirtane, Jeffrey D. Ward, Frederick L. Locke, Maria Pia Morelli, Matthew S. Block, Ramez N. Eskander, Wendy J. Langeberg, (unknown), (unknown), William Y. Go, David G. Maloney, Marcela V. Maus, John S. Welch, Julian R. Molina	5
4	Detecting HLA loss of heterozygosity within a standard diagnostic sequencing workflow for prognostic and therapeutic opportunities 2024 ·npj Precision Oncology ·(unknown), (unknown), Qidi Yang, Mario G. Rosasco, John S. Welch, William Y. Go, (unknown), Armen Mardiros, David G. Maloney, Edward B. Garon, Kedar Kirtane, Diane M. Simeone, Julian R. Molina, Ameen A. Salahudeen, Michelle M. Stein, J. Randolph Hecht	5
5	Recurrent transcriptional responses in AML and MDS patients treated with decitabine 2022 ·Experimental Hematology ·Pawan Upadhyay, (unknown), Nakul M. Shah, (unknown), Christopher A. Miller, Allegra A. Petti, Sai Mukund Ramakrishnan, Daniel C. Link, Timothy J. Ley, John S. Welch	10
6	Focal disruption of DNA methylation dynamics at enhancers in IDH-mutant AML cells 2021 ·Leukemia ·(unknown), Nichole Helton, Sharon E. Heath, Robert S. Fulton, Jacqueline E. Payton, John S. Welch, Matthew J. Walter, Peter Westervelt, John F. DiPersio, Daniel C. Link, Christopher A. Miller, Timothy J. Ley, David H. Spencer	19
7	RXRA DT448/9PP generates a dominant active variant capable of inducing maturation in acute myeloid leukemia cells 2021 ·Haematologica ·(unknown), (unknown), Gayla Hadwiger, (unknown), (unknown), María Piedad Menéndez-Gutierrez, Mercedes Ricote, John S. Welch	6
8	Patterns of mutations in TP53 mutated AML 2018 ·Best Practice & Research Clinical Haematology ·John S. Welch	41
9	Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10‐day decitabine regimen 2017 ·Cancer Medicine ·Alaa M. Ali, (unknown), Feng Gao, Geoffrey L. Uy, Amanda F. Cashen, Meagan A. Jacoby, Lukas D. Wartman, Armin Ghobadi, Iskra Pusic, Rizwan Romee, Todd A. Fehniger, Keith Stockerl‐Goldstein, Ravi Vij, Stephen T. Oh, Camille N. Abboud, Mark A. Schroeder, Peter Westervelt, John F. DiPersio, John S. Welch	21
10	Endogenous retinoid X receptor ligands in mouse hematopoietic cells 2017 ·Science Signaling ·Haixia Niu, Hideji Fujiwara, (unknown), Gayla Hadwiger, Thomas E. Frederick, María Piedad Menéndez-Gutierrez, Mercedes Ricote, Gregory R. Bowman, John S. Welch	17
11	CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression 2017 ·Cell ·David H. Spencer, David A. Russler‐Germain, Shamika Ketkar, Nichole Helton, Tamara Lamprecht, Robert S. Fulton, Catrina C. Fronick, Michelle D. O’Laughlin, Sharon E. Heath, Marwan Shinawi, Peter Westervelt, Jacqueline E. Payton, Lukas D. Wartman, John S. Welch, Richard K. Wilson, Matthew J. Walter, Daniel C. Link, John F. DiPersio, Timothy J. Ley	149
12	SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution 2014 ·PLoS Computational Biology ·Christopher A. Miller, Brian S. White, Nathan D. Dees, Malachi Griffith, John S. Welch, Obi L. Griffith, Ravi Vij, Michael H. Tomasson, Timothy A. Graubert, Matthew J. Walter, Matthew J. Ellis, William Schierding, John F. DiPersio, Timothy J. Ley, Elaine R. Mardis, Richard K. Wilson, Li Ding	281
13	Mutational landscape and significance across 12 major cancer types breakdown → 2013 ·Nature ·Cyriac Kandoth, Michael D. McLellan, Fabio Vandin, Kai Ye, Beifang Niu, Charles Lu, Mingchao Xie, Qunyuan Zhang, Joshua F. McMichael, Matthew A. Wyczalkowski, Mark D.M. Leiserson, Christopher A. Miller, John S. Welch, Matthew J. Walter, Michael C. Wendl, Timothy J. Ley, Richard K. Wilson, Benjamin J. Raphael, Li Ding	3134
14	PML-RARA can increase hematopoietic self-renewal without causing a myeloproliferative disease in mice 2011 ·Journal of Clinical Investigation ·John S. Welch, Wenlin Yuan, Timothy J. Ley	25
15	Therapy related acute myeloid leukemia in breast cancer survivors, a population-based study 2009 ·Breast Cancer Research and Treatment ·Mike G. Martin, John S. Welch, Jingqin Luo, Matthew J. Ellis, Timothy A. Graubert, Matthew J. Walter	36
16	Interleukin-4 induction of the CC chemokine TARC (CCL17) in murine macrophages is mediated by multiple STAT6 sites in the TARC gene promoter 2006 ·BMC Molecular Biology ·Kate Liddiard, John S. Welch, Jean Lozach, Sven Heinz, Christopher K. Glass, David R. Greaves	48
17	Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase breakdown → 1999 ·Nature ·(unknown), John S. Welch, Mercedes Ricote, Christoph J. Binder, Timothy M. Willson, Carolyn Kelly, Joseph L. Witztum, Colin Funk, Douglas Conrad, (unknown)	749
18	Linitis Plastica Caused by Metastatic Lobular Carcinoma of the Breast 1980 ·Mayo Clinic Proceedings ·(unknown), (unknown), (unknown), John S. Welch, J H Edmonson	76
19	Primary leiomyosarcoma of the vagina 1963 ·American Journal of Obstetrics and Gynecology ·George D. Malkasian, John S. Welch, Edward H. Soule	22
20	RECURRENT INTESTINAL OBSTRUCTION DUE TO GALLSTONES 1957 ·Mayo Clinic Proceedings ·John S. Welch, Kenneth A. Huizenga, (unknown)	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact